课题基金 / 基金详情

ACYCLIC PROTEGRIN ANALOGUES AS ANTIMICROBIAL AGENTS

ACYCLIC PROTEGRIN ANALOGUES AS ANTIMICROBIAL AGENTS
作为抗菌剂的无环保护蛋白类似物
批准号:
7381337
负责人:
DEWAYNE LOGAN
金额:
$2.81万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-05-01 至 2007-04-30

项目摘要

项目成果

DEWAYNE LOGAN的其他基金

相似基金

相关文献

中文摘要
翻译
本子项目是利用由NIH/NCRR资助的中心赠款提供的资源的众多研究子项目之一。子项目和研究者(PI)可能已经从另一个NIH来源获得了主要资金,因此可以在其他CRISP条目中表示。列出的机构是中心的,不一定是研究者的机构。蛋白蛋白是一种含半胱氨酸的无环β -片肽,具有广谱抗菌活性,能杀死多种微生物。由于即使是最有效的抗生素也出现耐药性,因此开发新的抗菌肽势在必行。非半胱氨酸蛋白蛋白类似物正在合成,以尽量减少氧化和困难的脱保护二硫键。PI的长期目标是阐明影响非半胱氨酸肽生物活性的必要氨基酸残基,作为开发非半胱氨酸肽作为治疗剂的必要前提。具体的假设是,取代胍残基和季铵基团的掺入会增加这些类似物的生物活性。这一假设基于以下观察:1)取代胍基残基可以促进与复合受体的结合;2)季铵盐化合物可以作为消毒剂、防腐剂和防腐剂。基于这些观察,重点是设计新的抗菌肽。具体目标是:1。含全取代胍残基和季铵基的非半胱氨酸肽类似物的合成。类似物将在自动固相合成器上使用标准的Fmoc脱保护化学合成。2. 非半胱氨酸肽类似物的二级结构的阐明。两亲结构将被阐明使用圆二色性分析,以确定从原始的β -片结构的任何变化。3. 非半胱氨酸肽类似物生物活性的确认。类似物的生物活性将使用最低抑制浓度(MIC)协议在各种微生物上进行测试。
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Protegrins are acyclic, cysteine containing beta-sheet peptides that have shown extremely broad-spectrum antimicrobial activity, killing a diverse array of microorganisms. Because resistance is appearing to even the most potent antibiotics, the development of new antimicrobial peptides is imperative. Non-cysteine protegrin analogues are being synthesized to minimize oxidation and difficult deprotection of the disulfide linkage. The PI's long-term goal is to elucidate the necessary amino acid residues affecting the bioactivity of the as necessary prerequisite to the development of non-cysteine peptides as therapeutic agents. The specific hypothesis is that the incorporation of substituted guanidine residues and quaternary ammonium groups would increase the bioactivity of these analogues. This hypothesis is based on the observations that 1) substituted guanidine residues can facilitate binding to complex receptors and 2) quaternary ammonium compounds serve as disinfectants, antiseptics, and preservatives. Based on these observations, the focus is to design new antimicrobial peptides. The specific aims are: 1. Synthesis of non-cysteine peptide analogues incorporated with fully substituted guanidine residues and quaternary ammonium groups. The analogues will be synthesized using standard Fmoc deprotection chemistry on an automated solid phase synthesizer. 2. Elucidation of the secondary structure of the non-cysteine peptide analogues. The amphipathic structures will be elucidated using circular dichroism analysis to determine any change from the original beta-sheet structure. 3. Confirmation of bioactivity of non-cysteine peptide analogues. The bioactivity of the analogues will be tested on various microorganisms using minimum inhibitory concentration (MIC) protocols.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CHEMOSENSOR FOR DETECTION OF ANTIMICROBIAL ACTIVITY
海外基金